Ca2+ is a ubiquitous cellular signal. Altered expression of specific Ca2+ channels and pumps are characterizing features of some cancers. The ability of Ca2+ to regulate both cell death and proliferation, combined with the potential for pharmacological modulation, offers the opportunity for a set of new drug targets in cancer. However, the ubiquity of the Ca2+ signal is often mistakenly presumed to thwart the specific therapeutic targeting of proteins that transport Ca2+. This Review presents evidence to the contrary and addresses the question: which Ca2+ channels and pumps should be targeted?
机构:
Univ Calif San Francisco, Vet Adm Med Ctr, Dept Med, San Francisco, CA 94121 USAUniv Calif San Francisco, Vet Adm Med Ctr, Dept Med, San Francisco, CA 94121 USA
Bikle, DD
Oda, Y
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, Vet Adm Med Ctr, Dept Med, San Francisco, CA 94121 USA
Oda, Y
Xie, Z
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, Vet Adm Med Ctr, Dept Med, San Francisco, CA 94121 USA
机构:
Univ Calif San Francisco, Vet Adm Med Ctr, Dept Med, San Francisco, CA 94121 USAUniv Calif San Francisco, Vet Adm Med Ctr, Dept Med, San Francisco, CA 94121 USA
Bikle, DD
Oda, Y
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, Vet Adm Med Ctr, Dept Med, San Francisco, CA 94121 USA
Oda, Y
Xie, Z
论文数: 0引用数: 0
h-index: 0
机构:Univ Calif San Francisco, Vet Adm Med Ctr, Dept Med, San Francisco, CA 94121 USA